Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD79a anticorps (AA 202-216)

CD79A Reactivité: Humain, Souris, Rat, Boeuf (Vache), Porc, Singe FACS, IF, IHC (p) Hôte: Lapin Monoclonal IGA-1790R unconjugated Recombinant Antibody
N° du produit ABIN5646922
  • Antigène Voir toutes CD79a (CD79A) Anticorps
    CD79a (CD79A) (B-cell antigen receptor complex-associated protein alpha chain (CD79A))
    Type d'anticorp
    Recombinant Antibody
    Épitope
    • 69
    • 25
    • 11
    • 10
    • 8
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 202-216
    Reactivité
    • 191
    • 102
    • 81
    • 52
    • 51
    • 32
    • 28
    • 26
    • 26
    • 26
    • 16
    • 10
    • 5
    • 5
    • 2
    • 1
    Humain, Souris, Rat, Boeuf (Vache), Porc, Singe
    Hôte
    • 104
    • 101
    • 3
    • 1
    Lapin
    Clonalité
    • 126
    • 82
    • 1
    Monoclonal
    Conjugué
    • 92
    • 19
    • 16
    • 15
    • 15
    • 8
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CD79a est non-conjugé
    Application
    • 119
    • 97
    • 64
    • 58
    • 45
    • 25
    • 22
    • 15
    • 10
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    Purified
    Pureté
    Protein A affinity chromatography
    Immunogène
    Amino acids 202-216 (GTYQDVGSLNIADVQ) were used as the immunogen for the recombinant CD79a antibody.
    Clone
    IGA-1790R
    Isotype
    IgG kappa
    Top Product
    Discover our top product CD79A Anticorps primaire
  • Indications d'application
    Optimal dilution of the recombinant CD79a antibody should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,IHC (FFPE): 0.25-0.5 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)

    Restrictions
    For Research Use only
  • Concentration
    0.2 mg/mL
    Buffer
    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store the recombinant CD79a antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Antigène
    CD79a (CD79A) (B-cell antigen receptor complex-associated protein alpha chain (CD79A))
    Autre désignation
    CD79a (CD79A Produits)
    Synonymes
    anticorps CD79A, anticorps Ig-alpha, anticorps Iga, anticorps Igalpha, anticorps Ly-54, anticorps Ly54, anticorps mb-1, anticorps IGA, anticorps MB-1, anticorps IG-alpha, anticorps CD79a molecule, anticorps CD79A antigen (immunoglobulin-associated alpha), anticorps Cd79a molecule-like, anticorps CD79A, anticorps Cd79a, anticorps Cd79al
    Sujet
    A disulphide-linked heterodimer, consisting of mb-1 (or CD79a) and B29 (or CD79b) polypeptides, is non-covalently associated with membrane-bound immunoglobulins on B cells. This complex of mb-1 and B29 polypeptides and immunoglobulin constitute the B cell Ag receptor. CD79a first appears at pre B cell stage, early in maturation, and persists until the plasma cell stage where it is found as an intracellular component. CD79a is found in the majority of acute leukemias of precursor B cell type, in B cell lines, B cell lymphomas, and in some myelomas. It is not present in myeloid or T cell lines. Anti-CD79a is generally used to complement anti-CD20 especially for mature B-cell lymphomas after treatment with Rituximab (anti-CD20). This antibody will stain many of the same lymphomas as anti-CD20, but also is more likely to stain B-lymphoblastic lymphoma/leukemia than is anti-CD20. Anti-CD79a also stains more cases of plasma cell myeloma and occasionally some types of endothelial cells as well.
    Pathways
    BCR Signaling
Vous êtes ici:
Support technique